BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10636800)

  • 1. DNA cuts its teeth--as an enzyme.
    Finkel E
    Science; 1999 Dec; 286(5449):2441-2. PubMed ID: 10636800
    [No Abstract]   [Full Text] [Related]  

  • 2. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury.
    Santiago FS; Lowe HC; Kavurma MM; Chesterman CN; Baker A; Atkins DG; Khachigian LM
    Nat Med; 1999 Nov; 5(11):1264-9. PubMed ID: 10545992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipoproteins on the expression of the early growth response gene-1 and on DNA synthesis in rat vascular smooth muscle cells.
    Sachinidis A; Ko Y; Schulte KB; Appenheimer M; Seul C; Meyer zu Brickwedde MK; Nickenig G; Vetter H
    J Hypertens Suppl; 1993 Dec; 11(5):S116-7. PubMed ID: 8158302
    [No Abstract]   [Full Text] [Related]  

  • 4. Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.
    Khachigian LM
    J Clin Invest; 2000 Nov; 106(10):1189-95. PubMed ID: 11086018
    [No Abstract]   [Full Text] [Related]  

  • 5. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
    Fahmy RG; Khachigian LM
    Nucleic Acids Res; 2004; 32(7):2281-5. PubMed ID: 15107496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
    Santiago FS; Atkins DG; Khachigian LM
    Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis.
    Lowe HC; Fahmy RG; Kavurma MM; Baker A; Chesterman CN; Khachigian LM
    Circ Res; 2001 Oct; 89(8):670-7. PubMed ID: 11597989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury.
    Fahmy RG; Khachigian LM
    J Cell Biochem; 2002; 84(3):575-82. PubMed ID: 11813262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries.
    Lowe HC; Chesterman CN; Khachigian LM
    Thromb Haemost; 2002 Jan; 87(1):134-40. PubMed ID: 11848443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury.
    Silverman ES; Khachigian LM; Santiago FS; Williams AJ; Lindner V; Collins T
    Am J Pathol; 1999 Oct; 155(4):1311-7. PubMed ID: 10514413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet?
    Lowe HC; Khachigian LM
    Circulation; 2002 Jan; 105(4):E29. PubMed ID: 11815443
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
    Ko Y; Totzke G; Graack GH; Heidgen FJ; Meyer zu Brickwedde MK; Düsing R; Vetter H; Sachinidis A
    J Hypertens; 1993 Nov; 11(11):1171-8. PubMed ID: 8301097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat.
    Sachinidis A; Ko Y; Wieczorek A; Weisser B; Locher R; Vetter W; Vetter H
    Biochem Biophys Res Commun; 1993 Apr; 192(2):794-9. PubMed ID: 8484785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats.
    Nakamura H; Isaka Y; Tsujie M; Rupprecht HD; Akagi Y; Ueda N; Imai E; Hori M
    Gene Ther; 2002 Apr; 9(8):495-502. PubMed ID: 11948374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picture story. Clues to a patient revolution.
    Nat Struct Biol; 1998 Jul; 5(7):532. PubMed ID: 9665163
    [No Abstract]   [Full Text] [Related]  

  • 16. Catalytic DNA: in training and seeking employment.
    Breaker RR
    Nat Biotechnol; 1999 May; 17(5):422-3. PubMed ID: 10331790
    [No Abstract]   [Full Text] [Related]  

  • 17. A role for an alternatively spliced Id3 isoform in vascular lesions?
    Christy BA
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):727-8. PubMed ID: 11348865
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo.
    Nickenig G; Baudler S; Müller C; Werner C; Werner N; Welzel H; Strehlow K; Böhm M
    FASEB J; 2002 Jul; 16(9):1077-86. PubMed ID: 12087069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general purpose RNA-cleaving DNA enzyme.
    Santoro SW; Joyce GF
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4262-6. PubMed ID: 9113977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.